Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1631-1640 of 2905 for cancer

Edit search filters
  1. Combination Vaccine Immunotherapy (DRibbles) For Patients With Definitively-treated Stage III Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  2. A Study Of Selpercatinib To Treat Participants With RET-Mutant Medullary Thyroid Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Nivolumab With Or Without Ipilimumab In Treating Patients With Refractory Metastatic Anal Canal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Staging Prostate Cancer With Hybrid C11-Choline PET/MR And MpMRI

    Scottsdale/Phoenix, AZ

  5. Post Operative Adjuvant Therapy De-intensification Trial For Human Papillomavirus-related, P16+ Oropharynx Cancer

    Scottsdale/Phoenix, AZ

  6. A Study Of ABBV-085, An Antibody Drug Conjugate, For Patients With Advanced Solid Cancer Tumors

    Scottsdale/Phoenix, AZ

  7. A Study Of Ramucirumab Plus Docetaxel In Patients With Urothelial Cancer

    Rochester, MN

  8. ASCENT-Study Of Sacituzumab Govitecan In Refractory/Relapsed Triple-Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. (Z)-Endoxifen For The Treatment Of Premenopausal Women With ER+/HER2- Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Lower Or Standard Dose Regorafenib In Treating Patients With Refractory Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer